Filing Details

Accession Number:
0001352414-12-000017
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-10-03 17:09:33
Reporting Period:
2012-10-02
Filing Date:
2012-10-03
Accepted Time:
2012-10-03 17:09:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352414 S James Evans 320 Wakara Way
Salt Lake City UT 84108
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-10-02 578 $5.89 47,349 No 4 M Direct
Common Stock Disposition 2012-10-02 578 $28.06 46,771 No 4 S Direct
Common Stock Acquisiton 2012-10-02 30,630 $5.89 77,401 No 4 M Direct
Common Stock Disposition 2012-10-02 30,630 $28.06 46,771 No 4 S Direct
Common Stock Acquisiton 2012-10-02 3,792 $5.89 50,563 No 4 M Direct
Common Stock Disposition 2012-10-02 3,792 $28.06 46,771 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2012-10-02 578 $0.00 578 $5.89
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-10-02 30,630 $0.00 30,630 $5.89
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-10-02 3,792 $0.00 3,792 $5.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-09-08 No 4 M Direct
3,792 2014-09-08 No 4 M Direct
0 2014-09-08 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  2. The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.